Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (45)

2024

  1. Current drug strategies for the treatment and control of schistosomiasis

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 4, pp. 409-420

  2. Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?

    Medicinal Research Reviews, Vol. 44, Núm. 3, pp. 1055-1120

2022

  1. A comparative study of liposomes and chitosomes for topical quercetin antioxidant therapy

    Journal of Drug Delivery Science and Technology, Vol. 68

  2. Evaluation of the Immunomodulatory Effect of the Recombinant 14-3-3 and Major Antigen Proteins of Strongyloides stercoralis against an Infection by S. venezuelensis

    Vaccines, Vol. 10, Núm. 8

  3. External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924

  4. Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 222-227

  5. Model-Informed Precision Dosing (MIPD)

    Pharmaceutics

  6. Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  7. Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution

    Pharmaceutics, Vol. 14, Núm. 2

  8. Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK

    Frontiers in Pharmacology, Vol. 13

  9. Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients

    Pharmaceutics, Vol. 14, Núm. 4

  10. Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients

    European Journal of Pharmaceutical Sciences, Vol. 168

  11. Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction

    Frontiers in Immunology, Vol. 13